Mettler-Toledo International Inc. (MTD) and Microbot Medical Inc. (NASDAQ:MBOT) Contrasting side by side

As Medical Instruments & Supplies companies, Mettler-Toledo International Inc. (NYSE:MTD) and Microbot Medical Inc. (NASDAQ:MBOT) are our subject to contrast. And more specifically their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mettler-Toledo International Inc. 707 2.79 23.89M 20.91 36.20
Microbot Medical Inc. 5 0.00 3.61M -2.45 0.00

We can see in table 1 the earnings per share, top-line revenue and valuation of Mettler-Toledo International Inc. and Microbot Medical Inc.

Profitability

Table 2 provides us Mettler-Toledo International Inc. and Microbot Medical Inc.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mettler-Toledo International Inc. 3,380,596.59% 95.9% 20.5%
Microbot Medical Inc. 73,204,363.87% -123.2% -86.6%

Risk and Volatility

A beta of 1.32 shows that Mettler-Toledo International Inc. is 32.00% more volatile than Standard and Poor’s 500. Competitively, Microbot Medical Inc.’s 388.00% volatility makes it more volatile than Standard and Poor’s 500, because of the 4.88 beta.

Liquidity

The current Quick Ratio of Mettler-Toledo International Inc. is 1 while its Current Ratio is 1.4. Meanwhile, Microbot Medical Inc. has a Current Ratio of 3 while its Quick Ratio is 3. Microbot Medical Inc. is better positioned to pay off its short-term and long-term debts than Mettler-Toledo International Inc.

Analyst Recommendations

The next table highlights the given recommendations and ratings for Mettler-Toledo International Inc. and Microbot Medical Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Mettler-Toledo International Inc. 2 1 0 2.33
Microbot Medical Inc. 0 0 1 3.00

Mettler-Toledo International Inc.’s downside potential is -4.33% at a $700 average price target. Meanwhile, Microbot Medical Inc.’s average price target is $10, while its potential upside is 102.02%. Based on the analysts belief we can conclude, Microbot Medical Inc. is looking more favorable than Mettler-Toledo International Inc.

Insider & Institutional Ownership

Institutional investors owned 99.3% of Mettler-Toledo International Inc. shares and 24.7% of Microbot Medical Inc. shares. Insiders owned 0.4% of Mettler-Toledo International Inc. shares. Competitively, 20.62% are Microbot Medical Inc.’s share owned by insiders.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Mettler-Toledo International Inc. -6.82% -10.37% 2.38% 19.56% 30.07% 33.8%
Microbot Medical Inc. -5.34% 36.29% -12.09% -16.85% -24.11% 301.74%

For the past year Mettler-Toledo International Inc. has weaker performance than Microbot Medical Inc.

Summary

Mettler-Toledo International Inc. beats Microbot Medical Inc. on 7 of the 13 factors.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; reaction engineering and real-time analytic systems used in drug and chemical compound development; process analytics instruments used for in-line measurement in production processes; and end-of-line inspection systems used in production and packaging for food, pharmaceutical, and other industries. Its laboratory instruments include laboratory balances, liquid pipetting solutions, titrators, physical value analyzers, and thermal analysis systems, as well as other analytical instruments, such as moisture analyzers and density refractometers; and LabX, a PC-based laboratory embedded software platform. The companyÂ’s industrial solutions comprise industrial weighing instruments and terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of multiple weighing and food labeling solutions, stand-alone scales, and networked scales and software for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry covering pharmaceutical and biotechnology companies, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; transportation and logistics, metals, and electronics industries; and the academic community. The company markets its products through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is based in Columbus, Ohio.

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The companyÂ’s product candidates include Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and TipCAT, a semi-disposable, flexible, and self-propelled endoscope for use in colonoscopy procedures, as well as ViRob, a revolutionary autonomous crawling micro-robot technology, which can be controlled remotely or within the body. Microbot Medical Inc. was founded in 2010 and is based in Yokneam, Israel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.